Hepatitis associated aplastic Anemia: Case report and discussion

Connecticut Medicine

Volumn 78, Issue 8, 2014, Pages 493-495

  Khurana, Arushi ^a   Dasanu, Constantin A ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Saint Francis Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT;

ADULT; APLASTIC ANEMIA; ARTICLE; CASE REPORT; DIET SUPPLEMENTATION; HEPATITIS; HUMAN; MALE; YOUNG ADULT;

ADULT; ANABOLIC AGENTS; ANEMIA, APLASTIC; DIETARY SUPPLEMENTS; HEPATITIS; HUMANS; MALE; YOUNG ADULT;

EID: 84908232524     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Marsh JC, Darbyshire P, Gordon-Smith EC, et al. British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol. 2003;123(5):782-801.
2. Young NS, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8): 2509-2519.
3. Brown KE, Barrett AJ, Dunbar CE, et al. Hepatitis-associated aplastic anemia. N Engl J Med. 1997;336(15):1059-1064.
4. Cengiz C, Yolcu OF, Yilmaz S. Hepatitis associated with aplastic anemia: do CD8 (+) kupffer cells have a role in the pathogenesis? Dig Dis Sci. 2007; 2(9):2438-2443.
5. Pongtanakul B, Charpentier K, Dror Y. Outcome of children with aplastic anemia treated with immunosuppressive therapy. Pediatr Blood Cancer. 2008;50(1):52-57.
6. Führer M, Baumann I, Faldum A, et al. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood. 2005;106(6):2102-2104.
7. Lorenz E. Panmyelopathy following epidemic hepatitis. Wien Med Wochenschr. 1955;105(1):19-22.
8. Lu J, Meienhorst JJ, Young NS, et al. Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood. 2004;103(12):4588-4593.
9. Tzakis AG, Whitington PF, Yanaga K, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med. 1988;319(7):393-396.
10. Cattral MS, Markin RS, Antonson DL, et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology. 1994;20(4):831-838.
11. Honkaniemi E, Fischler B, Nemeth A et al. Acquired aplastic anaemia in seven children with severe hepatitis with or without liver failure. Acta Paediatr. 2007;96(11):1660-1664.
12. Itterbeek P, Nevens F, Fevery J et al. Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature. Trampl Int. 2002;15(2-3):117-123.
13. Safadi R, Ilan Y, Naparstek E, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant. 2001;27(2):183-190.
14. Ohara A, Okamura J, Inada H, et al. Aplastic Anaemia Committee of the Japanese Society of Pediatric Haematology. Evolution of myelodysplastic syndrome and acute myelogenous leukaemia in children with hepatitis-associated aplastic anaemia. Br J Haematol. 2002;116(1):151-154.
15. Davies JK. An update on the management of severe idiopathic aplastic anaemia in children. Br J Haematol. 2007;136(4):549-564.
16. Gonzalez-Casas R, Jones EA, Gisbert JP, et al. Systematic review: hepatitis-associated aplastic anaemia - a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther. 2009;30(5):436-443.
17. Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol. 2008;15:162-8
18. Savage WJ, DeRusso PA, Resar LM, et al. Treatment of hepatitis-associated aplastic anemia with high dose cyclophosphamide. Pediatr Blood Cancer. 2007;49:947-51.
19. El Snerrif Y, Potts JR, Howard MR, et al. Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations? Liver Int. 2013 Sep;33(8):1266-70.